Announcements Trials

Browse Landscape

Phase

Phase 2 23 Phase 3 13 Phase 1 4 Phase NA 2 Phase 2/3 2 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Carboplatin 16 Pemetrexed 15 Cisplatin 15 Erlotinib Hydrochloride 13 icotinib 8 Propofol 7 Gefitinib 7 Gemcitabine 6 Docetaxel 6 endostar protein 5 Saline Solution 5 Paclitaxel 5 Nivolumab 5 Endostatins 5 tislelizumab 4 lorlatinib 4 anlotinib 4 Vinorelbine 4 Sevoflurane 4 Drug Therapy 4 Afatinib 4 pembrolizumab 3 durvalumab 3 atezolizumab 3 Zoledronic Acid 3 Radiotherapy 3 Dexamethasone 3 Acetaminophen 3 trilaciclib 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × aumolertinib × Thoracic × Clear all

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Unknown

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡